Authors: Gianni, L Dombernowsky, P Sledge, G Martin, M Amadori, D Arbuck, SG Ravdin, P Brown, M Messina, M Tuck, D Weil, C Winograd, B

Citation: L. Gianni et al., Cardiac function following combination therapy with paclitaxel and doxorubicin: An analysis of 657 women with advanced breast cancer, ANN ONCOL, 12(8), 2001, pp. 1067-1073

Authors: Bast, RC Ravdin, P Hayes, DF Bates, S Fritsche, H Jessup, JM Kemeny, N Locker, GY Mennel, RG Somerfield, MR

Citation: Rc. Bast et al., 2000 update of recommendations for the use of tumor markers in breast and colorectal cancer: Clinical practice guidelines of the American Society of Clinical Oncology, J CL ONCOL, 19(6), 2001, pp. 1865-1878

Authors: Bast, RC Ravdin, P Hayes, DF Bates, S Fritsche, H Jessup, JM Kemeny, N Locker, GY Mennel, RG Somerfield, MR

Citation: Rc. Bast et al., 2000 update of recommendations for the use of tumor markets in breast and colorectal cancer: Clinical practice guidelines for the American Society ofClinical Oncology (vol 19, pg 1865, 2001), J CL ONCOL, 19(21), 2001, pp. 4185-4188

Authors: Ravdin, P

Citation: P. Ravdin, The use of HER2 testing in the management of breast cancer, SEMIN ONCOL, 27(5), 2000, pp. 33-42

Authors: Elledge, RM Green, S Pugh, R Allred, DC Clark, GM Hill, J Ravdin, P Martino, S Osborne, CK

Citation: Rm. Elledge et al., Estrogen receptor (ER) and progesterone receptor (PgR), by ligand-binding assay compared with ER, PgR and pS2, by immuno-histochemistry in predictingresponse to tamoxifen in metastatic breast cancer: A Southwest Oncology Group Study, INT J CANC, 89(2), 2000, pp. 111-117

Authors: Petit, T Aylesworth, C Burris, H Ravdin, P Rodriguez, G Smith, L Peacock, N Smetzer, L Bellet, R Von Hoff, DD Rowinsky, EK

Citation: T. Petit et al., A phase I study of docetaxel and 5-fluorouracil in patients with advanced solid malignancies, ANN ONCOL, 10(2), 1999, pp. 223-229